170 related articles for article (PubMed ID: 35983919)
1. Development of targeted therapies in IgG4-related disease.
Nakayamada S; Tanaka Y
Mod Rheumatol; 2023 Mar; 33(2):266-270. PubMed ID: 35983919
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
3. B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
Lanzillotta M; Stone JH; Della-Torre E
Mod Rheumatol; 2023 Mar; 33(2):258-265. PubMed ID: 35983918
[TBL] [Abstract][Full Text] [Related]
4. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G4-Related Disease Manifesting as Isolated, Typical, and Nontypical Gastroesophageal Lesion: A Research of Literature Review.
Khan S; Zhu LP; Jiang K; Liu W; Chen X; Wang BM
Digestion; 2020; 101(5):506-521. PubMed ID: 31291621
[TBL] [Abstract][Full Text] [Related]
6. A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.
Della-Torre E; Bozzalla-Cassione E; Sciorati C; Ruggiero E; Lanzillotta M; Bonfiglio S; Mattoo H; Perugino CA; Bozzolo E; Rovati L; Arcidiacono PG; Balzano G; Lazarevic D; Bonini C; Falconi M; Stone JH; Dagna L; Pillai S; Manfredi AA
Arthritis Rheumatol; 2018 Jul; 70(7):1133-1143. PubMed ID: 29499100
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of IgG4-related disease: a critical review.
Maehara T; Moriyama M; Nakamura S
Odontology; 2019 Apr; 107(2):127-132. PubMed ID: 30019169
[TBL] [Abstract][Full Text] [Related]
8. New insights into immune cells cross-talk during IgG4-related disease.
Touzani F; Pozdzik A
Clin Immunol; 2019 Jan; 198():1-10. PubMed ID: 30419354
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids in the treatment of IgG4-related disease-Prospects for new international treatment guidelines.
Yoshifuji H; Umehara H
Mod Rheumatol; 2023 Mar; 33(2):252-257. PubMed ID: 35993488
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
12.
Zongfei J; Rongyi C; Xiaomeng C; Lili M; Lingying M; Xiufang K; Xiaomin D; Zhuojun Z; Huiyong C; Ying S; Lindi J
Front Immunol; 2020; 11():1272. PubMed ID: 32733444
[No Abstract] [Full Text] [Related]
13. IgG4-related disease administered dupilumab: case series and review of the literature.
Kanda M; Kamekura R; Sugawara M; Nagahata K; Suzuki C; Takano K; Takahashi H
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894196
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on current and emerging therapies for immunoglobulin G4-related disease.
Tanaka Y; Stone JH
Mod Rheumatol; 2023 Mar; 33(2):229-236. PubMed ID: 36408992
[TBL] [Abstract][Full Text] [Related]
15. [The different forms of IgG4-related disease].
Roeloffs MWK; Hubers LM; Oomens MAEM; Beuers U
Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212027
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report.
Otani T; Iwamoto H; Yoshida Y; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hirata S; Sugiyama E; Hattori N
J Asthma; 2022 Dec; 59(12):2395-2401. PubMed ID: 34937495
[No Abstract] [Full Text] [Related]
17. IgG4-related disease: advances in pathophysiology and treatment.
Peyronel F; Fenaroli P; Maritati F; Schleinitz N; Vaglio A
Expert Rev Clin Immunol; 2023 May; 19(5):537-547. PubMed ID: 36960748
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapy options for IgG4-related disease.
Lanzillotta M; Fernàndez-Codina A; Culver E; Ebbo M; Martinez-Valle F; Schleinitz N; Della-Torre E
Expert Rev Clin Immunol; 2021 May; 17(5):471-483. PubMed ID: 33689549
[TBL] [Abstract][Full Text] [Related]
19. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
20. The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease.
Hsieh SC; Shen CY; Liao HT; Chen MH; Wu CH; Li KJ; Lu CS; Kuo YM; Tsai HC; Tsai CY; Yu CL
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
